Share on Facebook. Opens in a new tab or window Share on Bluesky. Opens in a new tab or window Share on X. Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window A fully ...

New digital twin technology that allows a University of Virginia-developed artificial pancreas system to adapt to users’ changing needs – and lets users adjust the settings – has been shown to improve ...

New technology that allows a University of Virginia-developed artificial pancreas system to adapt to users’ changing bodies – and lets users test changes to how the system operates – improved control ...

Researchers will soon undertake one of the largest-ever long-term clinical trials of a system designed to help regulate blood sugar levels of individuals with type 1 diabetes mellitus. If the ...

For several years, JDRF-funded researchers at the University of Virginia Center for Diabetes Technology have been hard at work designing an artificial pancreas system that would allow individuals with ...

Developed under the direction of Assistant Professor Shady Farah of the Technion's Faculty of Chemical Engineering, and carried out with colleagues from MIT, Harvard University, Johns ...

JERUSALEM, Feb. 2 (Xinhua) -- Researchers in Israel and the United States have developed a living implant that acts as an artificial pancreas, a breakthrough that could one day eliminate the need for ...

Diabetes is on the rise worldwide. It is a permanent condition that requires care over a life time. To help manage it, an artificial pancreas system, which automatically measures blood sugar levels to ...

The global Artificial Pancreas Device System (APDS) market in terms of revenue was estimated to be worth $123.5 million in 2022 and is poised to reach $405.3 million by 2030, growing at a CAGR of 14.1 ...

Diabetes management technology pioneer Beta Bionics has achieved another milestone, successfully amassing $100 million in its latest Series D equity funding round. The recent accomplishment surpasses ...

The new iLet Bionic Pancreas system was cleared by the FDA for patients 6 and older with type 1 diabetes, the agency announced Friday. The pocket-sized system features the the Beta Bionics iLet ACE ...